CXCR2 and breast carcinoma: In the primary tumors developed by 4T1 mouse breast cancer cells, inhibition of either CCR2 or CXCR2 can reduce the number of macrophages [24,25], which also suggests the involvement of multiple chemokine signals in the macrophage accumulation in the tumor microenvironment.